Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Dongxu Chemical Science and Technology is a China-based manufacturer and trader of pharmaceutical raw materials, pharmaceutical intermediates, and related chemical products. Publicly available company profiles indicate that it supplies a range of anti-infective active pharmaceutical ingredients and intermediates, including chloramphenicol, florfenicol, ciprofloxacin hydrochloride, doxycycline, oxytetracycline, lincomycin, azithromycin, and other fine chemicals and additives. The business appears to operate primarily as an API and chemical supply company rather than a therapeutic drug developer, with commercial sales and export activity across international markets. Its operations are associated with Nanchang, Jiangxi, with some listings indicating manufacturing activity in Jingdezhen. There is no clear evidence of a proprietary clinical pipeline, novel drug platform, or human therapeutics development program.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Dongxu.